QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 0.628
-- x --
-- x --
-- - --
$ 0.51 - $ 7.31
1,610
na
2.9M
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lipella-pharmaceuticals-granted-us-patent-for-mri-based-detection-method-for-interstitial-cystitis-titled-systems-and-methods-of-detecting-interstitial-cystitis-extending-protection-through-2045

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) ("Lipella" or the "Company"), a clinical-stage biotechnology company...

 lipella-pharma-to-present-topline-data-from-first-two-dose-cohorts-of-ongoing-phase-2a-trial-of-lp-310-for-treatment-of-olp-at-2025-joint-international-meeting-of-aaom-and-eaom-in-las-vegas

Statistically significant safety and efficacy data from 0.25 mg and 0.50 mg cohorts to be presentedPresentation scheduled for T...

 lipella-pharmaceuticals-to-present-abstract-on-oral-lichen-planus-treatment-at-2025-aaomeaom-international-meeting-conference-on-global-transformation-in-oral-medicine

Joint meeting to be held in Las Vegas, May 14-17Presentation will be delivered by Dr. Alessandro Villa of Miami Cancer Institut...

 nano-cap-lipella-pharmaceuticals-stock-jumps-on-positive-trial-data-in-patients-with-sore-mouth-membranes

Lipella's LP-310 Phase 2a trial showed strong efficacy and safety for oral lichen planus. The company plans a Phase 2b tria...

Core News & Articles

SHOP: -11% | Shopify shares are trading lower following Q4 financial results. IINN: 33% | EXCLUSIVE: Inspira Technologies Tells...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION